Dyrupeg contains the active substance pegfilgrastim and is a biological medicine. It is a 'biosimilar medicine'; this means ...

Player grades: Thunder devour Nuggets in 125-93 Game 7 win to advance to WCF Photos: Best images from Thunder's 125-93 Game 7 win over Nuggets How to watch Nuggets vs. Thunder Game 7 today: Time, TV ...

Player grades: Thunder embarrassed by Timberwolves in 143-101 Game 3 loss Photos: Best images from Thunder's 143-101 Game 3 loss to Timberwolves How to watch Thunder vs. Timberwolves Game 3 today: ...

Adding subcutaneous daratumumab to KRd increased the likelihood of MRD negativity in patients with newly diagnosed MM, regardless of transplant eligibility.

Learn more about some of the signs and symptoms of neutropenia in newborns and why infants with HDFN may be at greater risk.

Adding tafasitamab to treatment with lenalidomide and rituximab improved outcomes in patients with relapsed or refractory follicular lymphoma.

Per ODAC and CHMP recommendations, subcutaneous daratumumab may become the first approved treatment for smoldering myeloma.

Approval was based on results from the Phase III inMIND trial, which demonstrated a statistically significant and clinically ...

Early results from the MagnetisMM-6 trial reveal promising efficacy of elranatamab, daratumumab, and lenalidomide in treating ...

The IsKia trial reveals that isatuximab enhances MRD negativity in newly diagnosed multiple myeloma, especially in high-risk ...

The FDA has approved tafasitamab in combination with lenalidomide and rituximab for adults with relapsed/refractory ...

Shorter venetoclax durations in patients with acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) yielded ...